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Surveillance systems for infectious diseases build the basis for 
effective public health measures in the prevention and control of 
infectious diseases. Assessing and improving the quality of such 
national surveillance systems is a challenge, as many different 
administrations and professions contribute to a complex system in 
which sensitive information must be exchanged in a reliable and 
timely fashion. We conducted a multidisciplinary quality circle on 
the national public health surveillance system in Germany which 
included clinicians, laboratory physicians, and staff from local and 
state health departments as well as from the Robert Koch-Institut. The 
recommendations resulting from the quality circle included proposals 
to change the federal law for the control of infectious diseases as 
well as practical activities such as the change of notification forms 
and the mailing of faxed information letters to clinicians. A number 
of recommendations have since been implemented, and some have 
resulted in measurable improvements. This demonstrates that the 
applied method of quality circle is a useful tool to improve the quality 
of national public health surveillance systems.
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Introduction
In 2001 the infectious disease control act (IfSG) in Germany 
resulted in the implementation of a completely restructured and 
technically modernised national surveillance system for notifiable 
infectious diseases. The most important changes were:
The number of diseases to be notified by physicians was reduced 
from 52 to 17, while the number of pathogens to be notified by 
laboratories was increased from 52 to 53. 
Case definitions were introduced whereby local health 
departments must verify notifications before reporting them to 
the next level.
The federal surveillance institute (Robert Koch-Institut, RKI) 
became the agency responsible for defining the technical 
standards by which data is to be reported to the national level, 
which has resulted in the implementation of a complex electronic 
database network. Local health departments (LHD) receive paper 
based case notifications from physicians or laboratories. LHDs 
forward the case reports electronically using software either 
produced by the RKI and offered free of charge or one of five 
commercially available software packages tailored for health 
department administration [1-3].
The Federal Ministry of Health in Germany formally asked all 16 
state health administrations and the RKI to report their experiences 
with the new infectious disease control law in order to collect 
suggestions for a future revision of the law. By 2003 the RKI had 
conducted a focus group discussion of public health physicians, a 




departments as part of our comprehensive quality management 
efforts [4-6]. On the basis of these studies we intended to assess the 
experiences with the new surveillance system by taking into account 
the different perspectives of the various professions and institutions 
contributing to this system. We decided to conduct a quality circle, 
which is an instrument of quality management, generally consisting in 
a group of stakeholders or other affected persons of a specific process 
who discuss, in a structured way, needs and ways to improve specific 
processes. The aim of this quality circle was to identify possibilities 
for technical or organisational improvements of the system and to 
recommend changes to be made in a potential revision of the legal 
framework.
Methods
The quality circle (QC) took place on 4-5 March 2003 in Berlin. 
Members of the different professions and institutions were invited and 
grouped by structural level of the surveillance system:
Notifiers: hospital clinicians (2 persons), general practitioners 
(2), and laboratory physicians (2)
Local public health level: public health nurses (2) and public 
health physicians (2)
State public health level: representative of state health department 
(1), medical epidemiologists in state surveillance institute (2)
Federal public health level: data management personnel at RKI 
(3), epidemiologists at RKI (3).
We selected the 19 participants according to the following criteria: 
the greatest possible number of states and geographic areas should 
be represented; groups representing the different levels should be 
of a similar size; only one participant could take part from any 
one employer or institution (with exception of RKI staff); and no 
participants with direct hierarchical relationships between each 
other could participate (so, for example, participants from local 
public health level must come from different states than participants 
from state public health level). Participation was voluntary. The 
participants came from the following eight of the 16 German states: 
Berlin, Brandenburg, Sachsen, Sachsen-Anhalt, Niedersachsen, 
Nordrheinwestphalen, Hessen, Baden-Wurttemberg. 
The QC was moderated by two external public health scientists. 
Both moderators were trained and experienced in moderating focus 
groups and in health system research and had no conflict of interest 
for the issue to be discussed. The QC was structured in two main 
phases:
The first phase was dedicated to problem identification. This phase 
was executed simultaneously in four homogenous groups (groups 1 
to 4, as described above). Each group had 2 hours to describe their 
experiences with the surveillance system and to compile issues for 
improvement. The groups were asked to present their results on a flip 
chart without presenting any suggestions on how improvement might 
be done. These presentations were then discussed in plenary.
Between the two phases, the study results of the focus group 
discussions, the survey among general practitioners, the survey 
among LHD and statistical evaluations of the surveillance system 
were presented to the participants [5-8]. 
The second phase was dedicated to identifying possible solutions to 
the identified problems. In contrast to the first phase, participants were 
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all structural levels. In this phase, participants were asked to identify 
possible solutions to the problems previously discussed. The following 
three questions served as a guide for this process: 
What can be done at each level to improve the quality of the 
system? 
How can cooperation be improved at the different interfaces? 
What should be taken into account during a revision of the 
infectious disease control act (IfSG)? 
The proposed solutions were discussed in plenary. The moderators 
collected the presented suggestions and new ideas that have come 
up during the discussion applying a card based (metaplan) Delphi 
technique [9]. The recommendations were clustered according to two 
categories: The first category contained recommendations that can be 
implemented under the current legal framework of the IfSG, while 
the second category consisted of recommendations that required 
changes of the IfSG. Recommendations of the first category were 
further sorted by the four different levels of implementation.
Results
First phase: problem identification
1. Problems identified by clinical and laboratory level (group 1):
1.1 Laboratory work for a notifiable disease is not always medically 
indicated but represents a burden on the clinician’s laboratory 
budget.
1.2 The notification form is not always readily available and the 
list of notifiable disease is not known to all clinicians.
1.3 The notification form is complicated.
1.4 Clinicians do not see the benefit of reporting, they are not 
reimbursed for the time involved in completing and sending the 
notification.
1.5 Clinicians are reluctant to notify, as they want to prevent their 
patients from being approached by the public health department. 
Laboratory notification often reach the LHD before the clinician has 
informed the patient about the result, which may lead to the situation 
that the patient first learns about his diagnosis from the LHD and not 
from his physician.
1.6 Laboratories are uncertain which laboratory results are to be 
notified and the respective case definitions do not always take newly 
introduced laboratory methods into account.
2. Problems identified by local public health level (group 2):
2.1 Notification of rotavirus results in a high workload without 
any public health consequences.
2.2 Clinicians refuse to provide patient data to LHD upon request 
if the LHD has received a laboratory notification (currently a strict 
interpretation of the law does not allow this).
2.3 Notifications by kindergartens and similar institutions often 
lack diagnostic precision as the kindergarten administrators have no 
medical training.
2.4 The evaluation of vaccination programs and recommendations 
has become difficult as various vaccine-preventable diseases are not 
longer notifiable under the IfSG.
2.5 Reporting of institutional outbreaks (such as nursing homes) 
require a high work load from the LHD.
2.6 Epidemiological data on some diseases of high public health 
importance are not notifiable according to the current law.
3. Problems identified by state public health level (group 3):
3.1 The role of surveillance centers at state level (often not 
identical with the public health administration of a state) is not legally 
defined, resulting in unclear responsibilities towards LHD and RKI.
3.2 Interfaces between commercial software and RKI software do 
not function well, resulting in data transmission or coding errors
3.3 Clinicians’ refusal to provide clinical patient data to LHD may 
hamper the application of case definitions.
4. Problems identified by federal public health level (group 4):
4.1 Data transfer discontinuity: Information already digitally 
formatted (e.g. by the laboratory IT system) is transferred to a paper-
based text format in order to complete the notification form, sent to 
the LHD where it must be converted back to a digital format.




the responsibility of the states, resulting in numerous problems of 
standardisation. (For example, some states have additional diseases 
or slightly different or complementary conditions, notifiable only in 
their states, causing confusion and lack of comparability.)
4.3 Insufficient user friendliness of various software packages 
causes incomplete or false data transmission.
4.4 The large quantity of surveillance data is not analysed and 
evaluated sufficiently.
Second phase: problem solution
The following recommendations were identified. They are not 
necessarily all supported by the authors of this paper:
First category: Recommendations that can be implemented without 
revision of the law.
Recommendations to clinicians and laboratories:
If a notifiable disease is diagnosed by a laboratory, the laboratory 
report to the clinician should contain a reminder that this disease 
is notifiable (in response to problem formulated under 1.2).
The association of laboratory physicians and other relevant 
associations should define (based on the national case definitions) 
the specific laboratory methods and findings that constitute a 
notifiable condition (1.6). 
Recommendations to local health departments (LHD):
Define clear contact details for disease notification within the 
LHD (1.2).
Improve availability of notification forms by sending sample 
forms to clinicians (1.2).
Produce mouse pads, plasticised memos, posters or other 
reminders that contain the list of notifiable diseases and distribute 
them to clinicians (1.2).
Simplify notification forms (1.3).
Improve visibility of LHDs by presenting the work of LHDs at 
scientific conferences in order to demonstrate the public health 
relevance of notification (1.4). 
Improve communication with clinicians (e.g. by distributing 
information letters, bulletins, and reports via fax or email and by 
personally welcoming new general practitioners in the county) (1.5).
Develop a notification form for outbreaks (2.5).
Recommendations to state health departments (SHD):
Improve availability of notification forms by publishing it in the 
journal of the state medical association (which implies, however, 
that a statewide uniform reporting form is established) (1.2).
Offer training on reportable diseases at medical schools (1.2).
Distribute epidemiological reports to LHDs (4.4).
Provide more training opportunities for LHD personnel (4.4). 
Recommendations to RKI:
Develop a proposal for simplified notification form (1.3).
Provide feedback on surveillance data, also through the journal 
of the national medical association (1.4, 4.4).
Revise case definitions (1.6).
Reduce the amount of data to be reported by LHDs (2.5). 
Improve software tool that facilitates identification of the 
appropriate LHD to notifying laboratories (4.1).
Develop a national standard for an interface between software 
used in laboratories and software used by LHDs (4.1).
Provide more training opportunities for LHD personnel (4.4). 
Recommendations for revision of infectious disease control law
Detailed provision of patient data by clinicians should be 
financially compensated (1.2). 
The law should request a national standard which defines which 
laboratory results are to be notified (1.6).
If more than one laboratory is involved in identification of 
specification of a pathogen, there must be a clear rule, defining 
which one of the laboratories has to notify the result (1.6).
Sporadic infections with rotavirus should be removed from the 
lists of notifiable diseases (2.1).
Clinicians must be obliged and allowed to provide patient data 
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Borelliosis and connatal cytomegaly virus infection should be 
considered for inclusion (2.4). 
Vaccine preventable diseases not yet included (such as pertussis 
and tetanus) and infectious meningitis of unknown origin should 
be included in the list of notifiable diseases (2.4).
Notification of hepatitis B and C virus infections should also 
include first diagnosed chronic illness and not be limited to acute 
infections (2.6).
Syphilis should no longer be notified anonymously, in order to 
allow LHDs to conduct investigations (2.6).
Surveillance units at state level must be given a clearly defined 
function within the law (3.1).
Data standards must be uniform and nationally standardised, 
including the LHD level (and not at state level as it is in the 
current version) (3.2).
Discussion
This quality circle generated a number of valuable suggestions 
and recommendations on how the current surveillance system could 
be further improved. A methodological variation to most quality 
circles was that we intentionally invited participants from all affected 
structural and administrative levels [10]. The two phase approach, 
in which homogenous grouping was followed by heterogeneous 
grouping, proved to be successful: Homogenous grouping in the 
phase of problem identification allowed the participants to express 
their worries and frustrations without having to worry about 
hierarchical relationships and conflicting interests that may arise 
when representatives of different administrative levels come together. 
The following phase of developing possible solutions then required an 
interhierarchical and interdisciplinary approach in order to avoid each 
structural level projecting the need for improvement to another level. 
The re-grouping also forced the participants to search for solutions 
to problems which they have not necessarily identified themselves, 
which supports a pragmatic approach to the process. The presentation 
of results from previous studies between the two phases allowed the 
participants to compare their individual experience with data resulting 
form more quantitative assessments.
We support the majority of the recommendations presented in 
the result section, but cannot comment on all of them in detail in 
this report. However, the most important issues supported by our 
experience and by results of other studies are certainly those that deal 
with standardisation of information technology and with measures 
to improve notification compliance. 
A number of recommendations have meanwhile been implemented, 
as can be seen in the following examples:
Delegates of the RKI have been called as external advisors by the 
Ministry of Health for the revision process of the IfSG, which 
provided the opportunity to feed the recommendations of this 
quality circle into the discussion process. It remains to be seen 
how far the revision will take into account technical and scientific 
necessities of the system and practical experiences of those who 
implement the law on a daily basis.
A number of laboratories are already providing physicians 
with complementary information on notification of infectious 
diseases.
In a pilot study with 44 representatively selected LHDs, mouse 
pads and information letters were distributed by fax to general 
practitioners. Preliminary analyses suggest that these measures 
have resulted in a significant increase of notifications [11;12]. 
In January 2004, a completely revised new edition of case 
definitions was published by the RKI [13;14].












e-government (Bund online 2005) which provided a feasibility 
study on how to design a system for electronic laboratory 
notifications. This process has, however, recently come to a 
temporary stop, as resources to progress to the implementation 
stage are not available [15].
RKI has released a simplified notification form, developed in 
cooperation with pilot LHDs and state health departments [12], 
which has generated a lively and positive response among state 
and local health departments.
The recommendations formulated in this quality circle have 
therefore already led to practical interventions and some of these 
have in turn had a measurable effect. This is a good indication that a 
quality circle, conducted in the above described manner, is an effective 
tool for quality improvement of public health surveillance systems. 
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